MLYS PEER ANALYSIS

Mineralys Therapeutics, Inc. Common Stock — metric-by-metric comparison with peers and the industry median

MLYSMineralys Therapeutics, Inc. Common Stock

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

MLYSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MLYS	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	29.96	18.06
P/B	3.95	6.38	—	2.24●	3.62
EV/EBITDA	—	120.20	—	10.35●	15.13
P/S	—	3.24	31.30	2.66●	10.65

Financial Health
Metric	MLYS	TLX	MSB	CSL	Ind. Median
Current Ratio	44.33●	1.43	—	2.57	5.90
Debt/Equity	—	112.3%	—	67.4%●	10.9%
NetDebt/EBITDA	—	13.13	—	2.22●	1.15

Profitability
Metric	MLYS	TLX	MSB	CSL	Ind. Median
Net Margin	—	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-31.0%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-30.1%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	—	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	MLYS	TLX	MSB	CSL	Ind. Median
Rev. Growth	-100.0%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	MLYS	SRPT	BHVN	AGIO	KOD	VCEL	Ind. Median
P/E	—	37.09●	—	—	—	111.07	18.06
P/B	3.95	1.60●	17.73	2.33	21.13	6.69	3.62
EV/EBITDA	—	22.38●	—	—	—	66.16	15.13
P/S	—	1.10●	—	39.17	—	8.16	10.65

Financial Health
Metric	MLYS	SRPT	BHVN	AGIO	KOD	VCEL	Ind. Median
Current Ratio	44.33●	4.63	7.41	14.19	3.54	5.18	5.90
Debt/Equity	—	68.9%	221.0%	3.2%●	139.2%	26.5%	10.9%
NetDebt/EBITDA	—	3.07	0.10	1.68	0.07	-1.44●	1.15

Profitability
Metric	MLYS	SRPT	BHVN	AGIO	KOD	VCEL	Ind. Median
Net Margin	—	3.0%	—	-639.8%	—	7.3%●	-125.7%
ROE	-31.0%	4.9%	-333.0%	-32.8%	-208.8%	6.6%●	-47.5%
ROA	-30.1%	2.0%	-140.0%	-30.8%	-76.4%	4.7%●	-35.8%
EBITDA Margin	—	5.7%	—	-633.4%	—	12.1%●	-105.8%

Growth + Dividend
Metric	MLYS	SRPT	BHVN	AGIO	KOD	VCEL	Ind. Median
Rev. Growth	-100.0%	-2.2%	-100.0%	78.3%●	-100.0%	22.4%	5.1%
NI Growth	—	—	—	—	—	620.7%	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MLYS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.